Skip to content

High-intensity Exercise After Acute Cardiac Event (HITCARE)

High-Intensity Exercise Training in Cardiac Rehabilitation After Acute Coronary Event - Randomized Controlled Trial

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02235753
Acronym
HITCARE
Enrollment
27
Registered
2014-09-10
Start date
2014-12-31
Completion date
2019-12-31
Last updated
2017-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Myocardial Infarction, Recurrent Myocardial Infarction, Unstable Angina Pectoris

Brief summary

Despite the well-known health benefits of physical exercise in the prevention of chronic diseases, less attention has been focused on the use of physical exercise as an essential part of good treatment for chronic disease. The aims of the study are to investigate the feasibility, medical effects, cost-effectiveness, and social perspectives of the individualized exercise-based rehabilitation \[2 different high-intensity training (HIT) protocols combined with usual care (UC)\] after acute coronary artery disease (CAD) event. The medical aim is to study mediating mechanisms of the physiological, biochemical and molecular effects of exercise training on the clinical outcomes. The aim of the health-economic evaluation is to assess the changes in the Health-Related Quality of Life (HRQL) and health care related costs for estimating the cost-effectiveness of HIT-based exercise rehabilitation. The purpose of the sociological analysis is to find out the social processes which make possible the emergence of the desired welfare effects.

Detailed description

The study population consists of patients living in the city of Kuopio or Siilinjarvi area in Eastern Finland, who have been treated in Kuopio University Hospital because of acute CAD event. After baseline measurements, the patients will be randomized into one of the 3 groups: short interval HIT protocol (HIT-S), long interval HIT protocol (HIT-L) or UC group. The intervention will be 12 months per patient and the expected duration of the whole study (intervention data collection) is estimated to be 4 years. In addition, all groups will have annual follow-up examinations scheduled up to 60 months after initiation of the intervention phase. The patients recruited for the study will be 750, a total of 250 patients per study group. All measurements related to intervention will be performed at Kuopio Research Institute of Exercise Medicine. Examinations concerning myocardial structure and perfusion will be done at Turku PET Center (subsample). The study complies with the Helsinki declaration, follows good clinical practice. Patient safety will follow normal medical practice. The intervention is not anticipated to cause health risks apart from the conventional treatment. All participants will be provided with diverse individualized information about their health and physical performance. The research methods employed in the study are safe. Physician and nurse will be present at each occasion when physically strenuous measurements are performed and careful provisions for appropriate first aid will be made. The measurements assessing cardiorespiratory and muscular fitness will involve hard effort and it is not unusual to feel innocent muscle pain for a few days after measurements demanding maximal effort. The other potential acute complications may include accidents (e.g. injuries due to slipping or falling) and medical emergencies like acute myocardial infarction. Study hypotheses: 1. Short (15 sec) and long interval (3 min) high-intensity aerobic interval training (HIT) combined with resistance training after acute CAD event are equally effective in improving cardiorespiratory fitness compared with UC. 2. Despite higher unit costs, the differences in health-related quality of life effects are so large that both HIT interventions are cost-effective compared with UC. 3. Patient's experiences and interpretation of HIT exercise as well as different social processes during rehabilitation explain the cost-effectiveness of the rehabilitation. 4. Patient groups who will or will not benefit of HIT interventions can be identified and predicted.

Interventions

BEHAVIORALHigh-intensity aerobic interval training, short interval

The intensity of HIT-S sessions (cycle ergometer) will be increased during 3 to 6 months from 60% of VO2peak to 100% which will be the target intensity from 6 to 12 months. The protocol includes four 6 min sets consisting of 15 sec exercise followed by 15 sec passive recovery separated with 3 min passive recovery between sets. Exercise session will last ca. 40 min, with 12 min of HIT, warm-up and recovery. The intensity of the 15 seconds exercise bouts will be based on VO2peak at baseline and after 6 months. Meanwhile, the estimated VO2peak from the submaximal test will be used to adjust the training intensity in HIT sessions. Training will be conducted in a group of 1-3 HIT-S patients with ECG monitoring and supervised by physician.

BEHAVIORALHigh-intensity aerobic interval training, long interval

The intensity of HIT-L sessions (cycle ergometer) will be increased during 3 to 6 months from 60% of VO2peak to 90% which will be the target intensity from 6 to 12 months. The protocol includes four 3 min exercise bouts with a 4 min recovery (pedaling at 0 W) between bouts. Exercise session will last ca. 40 min, with 12 min of HIT, warm-up and recovery. The intensity of the 3 min exercise bouts will be based on VO2peak at baseline and after 6 months. Meanwhile, the estimated VO2peak from the submaximal test will be used to adjust the training intensity in HIT sessions. Training will be conducted in a group of 1-3 HIT-L patients with ECG monitoring and supervised by physician.

Sponsors

Social Insurance Institution, Finland
CollaboratorOTHER
Kuopio University Hospital
CollaboratorOTHER
University of Eastern Finland
CollaboratorOTHER
University of Basel
CollaboratorOTHER
Kuopio Research Institute of Exercise Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* hospital care after acute CAD event (ICD-10 codes I20.0-I22) * age 40-80 years * signed informed consent form

Exclusion criteria

* conditions preventing regular exercise training * severe/malignant disease (life expectancy \<12 months)

Design outcomes

Primary

MeasureTime frame
Change in cardiorespiratory fitness as assessed by peak oxygen uptake (VO2peak)Baseline, 6 and 12 months

Secondary

MeasureTime frameDescription
Incremental health care cost/quality-adjusted life-year-relationBaseline, 6 and 12 months
Social processes explaining adherence and motivation to exercise rehabilitationBaseline, 6 and 12 monthsSocial analysis will be performed by specific questionnaires and interviews. Subjective perceptions on the social mechanisms impacting on health and well-being as a part of the rehabilitation processes will be also be modelled using comparative causal mapping techniques (CMT) (See http://www.uef.fi/fi/cmap3).
Total costs of the use of health care servicesBaseline, 6 and 12 monthsThe use of total health services will be assessed by diary, questionnaire and from registers (national, hospital district and domicile health center).
Utilization of health care resourcesBaseline, 6 and 12 months
Change in health-related quality of lifeBaseline, 6 and 12 months

Other

MeasureTime frameDescription
Sitting timeBaseline, 6 and 12 months
Dietary habitsBaseline, 6 and 12 monthsMeasured by food frequency questionnaire
Change in chest pain symptoms, exercise induced angina or ischemiaBaseline, 6 and 12 monthsComposite measure based on anamnesis and ECG
Change in antianginal and other medicationBaseline, 6 and 12 months
Hospitalization due to cardiovascular causesBaseline, 6 and 12 months
Change in vascular risk factorsBaseline, 6 and 12 months
Progression of peripheral atherosclerosisBaseline, 6 and 12 months
Change in cognitive functionBaseline and 12 months
Change in depressive symptomsBaseline, 6 and 12 months
Change in autonomic nervous system control of cardiac functionBaseline and 12 months
Change in myocardial blood flow capacity and left ventricular functionBaseline and 12 months
Change in myocardial blood flow at rest and during adenosine infusionBaseline and 12 months
Change in myocardial blood flow reserveBaseline and 12 months
Change in left ventricular ejection fractionBaseline and 12 months
Change in left ventricular longitudinal peak systolic strainBaseline and 12 months
Change in left mitral annular diastolic tissue velocityBaseline and 12 months
Change in anthropometric measuresBaseline, 6 and 12 monthsMeasured by body weight, body height, waist circumference, and hip circumference. Body mass index and waist to hip ratio will be calculated.
All-cause deathBaseline, 6 and 12 months; annual follow-up up to 60 months
Cardiovascular deathBaseline, 6 and 12 months; annual follow-up up to 60 months
Intervention related adverse eventsThroughout the intervention phase
Change in body compositionBaseline, 6 and 12 monthsMeasured by bioimpedance
Change in ergospirometer variablesBaseline, 6 and 12 months
Change in muscular performanceBaseline, 6 and 12 months
Change in daily energy expenditureBaseline, 6 and 12 months
Sleeping timeBaseline, 6 and 12 months

Countries

Finland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026